<p>* Hospital stays related to mRCC are defined by the combination of two set of codes for renal cell carcinoma and for metastases (Primary Diagnosis (PD) = C64 or Related Diagnosis (RD) = C64 or Significant Associated Diagnosis (SAD) = C64) and ((PD = C77 or or C78 or C79) or (RD = C77 or C78 or C79) or (SAD = C77 or C78 or C79)). ** Patients for whom a hospitalisation related to mRCC or a code of metastases were identified in the previous year, or where both metastases and renal cell carcinoma were coded as an SAD (SAD = C64 + SAD = (C77 or C78 or C79)).</p
This study evaluated the effects of metastasectomy on overall survival (OS) and progression-free sur...
BACKGROUND & OBJECTIVES:The aim of this study was to assess the economic burden of hospitalisations ...
The aim of the present retrospective analysis was to describe trends in exposure to multiple lines o...
BackgroundEvidence exists to suggest a pattern of increasing early diagnosis of renal cell carcinoma...
BACKGROUND: Vascular endothelial growth factor (VEGF), tyrosine kinase (TK) and mechanistic target o...
The International mRCC (metastatic renal cell carcinoma) Database Consortium (IMDC) is the standard ...
In metastatic renal-cell carcinoma (mRCC), physicians have a plethora of therapeutic choices, with t...
Importance: There exists considerable biological and clinical variability between histologic variant...
Out of a total of 383 patients with PSC managed at our centre, 208 patients received at least one ER...
<p>Patient and tumor characteristics of 86 cases of CRC stratified by MSI status.</p
International audienceBACKGROUND:Patient characteristics and survival outcomes in randomized trials ...
Patients with metastatic renal cell cancer (mRCC) for whom surgery is ineffective may experience a p...
Background: Despite important results achieved for metastatic renal cell carcinoma, some patients co...
<p>The Metastatic Renal Cell Cancer Registry, a large, nationally representative, prospective regist...
Background Several models are adopted in clinical practice to estimate prognosis of patients with...
This study evaluated the effects of metastasectomy on overall survival (OS) and progression-free sur...
BACKGROUND & OBJECTIVES:The aim of this study was to assess the economic burden of hospitalisations ...
The aim of the present retrospective analysis was to describe trends in exposure to multiple lines o...
BackgroundEvidence exists to suggest a pattern of increasing early diagnosis of renal cell carcinoma...
BACKGROUND: Vascular endothelial growth factor (VEGF), tyrosine kinase (TK) and mechanistic target o...
The International mRCC (metastatic renal cell carcinoma) Database Consortium (IMDC) is the standard ...
In metastatic renal-cell carcinoma (mRCC), physicians have a plethora of therapeutic choices, with t...
Importance: There exists considerable biological and clinical variability between histologic variant...
Out of a total of 383 patients with PSC managed at our centre, 208 patients received at least one ER...
<p>Patient and tumor characteristics of 86 cases of CRC stratified by MSI status.</p
International audienceBACKGROUND:Patient characteristics and survival outcomes in randomized trials ...
Patients with metastatic renal cell cancer (mRCC) for whom surgery is ineffective may experience a p...
Background: Despite important results achieved for metastatic renal cell carcinoma, some patients co...
<p>The Metastatic Renal Cell Cancer Registry, a large, nationally representative, prospective regist...
Background Several models are adopted in clinical practice to estimate prognosis of patients with...
This study evaluated the effects of metastasectomy on overall survival (OS) and progression-free sur...
BACKGROUND & OBJECTIVES:The aim of this study was to assess the economic burden of hospitalisations ...
The aim of the present retrospective analysis was to describe trends in exposure to multiple lines o...